Literature DB >> 11672434

Regulation of mammalian phospholipase D2: interaction with and stimulation by G(M2) activator.

S Sarkar1, N Miwa, H Kominami, N Igarashi, S Hayashi, T Okada, S Jahangeer, S Nakamura.   

Abstract

We have previously reported that a heat-stable activator for ganglioside metabolism, G(M2) activator, potently stimulates ADP-ribosylation factor (ARF)-dependent phospholipase D (PLD) activity (presumably PLD1) in an in vitro system [Nakamura, Akisue, Jinnai, Hitomi, Sarkar, Miwa, Okada, Yoshida, Kuroda, Kikkawa and Nishizuka (1998) Proc. Natl. Acad. Sci. U.S.A. 95, 12249-12253]. However, little is known about the regulation of PLD2. In the present studies we have investigated the regulation of PLD2 by G(M2) activator and various other regulators including ARF. PLD2 was potently stimulated in vitro by G(M2) activator in a time- and dose-dependent manner. Neither ARF nor protein kinase C caused any significant changes in PLD2 activity. Importantly, PLD2 responsiveness to ARF was greatly enhanced by G(M2) activator, suggesting a possible role for G(M2) activator as a coupling factor. G(M2) activator was also demonstrated to physically associate with PLD2 in a stoichiometric manner. Further, PMA stimulation of COS-7 cells overexpressing both G(M2) activator and PLD2 resulted in a marked increase in the association of the two molecules. Interestingly, ARF association with PLD2 was greatly increased by G(M2) activator. Moreover, G(M2) activator enhanced PMA-induced PLD activity in a synergistic manner with ARF in streptolysin-O-permeabilized, cytosol-depleted HL-60 cells, suggesting that G(M2) activator may regulate PLD in a concerted manner with other factors, including ARF, inside the cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672434      PMCID: PMC1222181          DOI: 10.1042/0264-6021:3590599

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

Review 1.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C.

Authors:  Y Nishizuka
Journal:  Science       Date:  1992-10-23       Impact factor: 47.728

2.  Purification of a heat-stable activator protein for ADP-ribosylation factor-dependent phospholipase D.

Authors:  T Akisue; H Jinnai; T Hitomi; N Miwa; K Yoshida; S Nakamura
Journal:  FEBS Lett       Date:  1998-01-23       Impact factor: 4.124

Review 3.  New developments in phospholipase D.

Authors:  J H Exton
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

4.  Over-expression of a functionally active human GM2-activator protein in Escherichia coli.

Authors:  H Klima; A Klein; G van Echten; G Schwarzmann; K Suzuki; K Sandhoff
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

5.  Reconstitution of GTP-gamma-S-dependent phospholipase D activity with ARF, RhoA, and a soluble 36-kDa protein.

Authors:  K Shimooku; T Akisue; H Jinnai; T Hitomi; C Ogino; K Yoshida; S Nakamura; Y Nishizuka
Journal:  FEBS Lett       Date:  1996-06-03       Impact factor: 4.124

6.  Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization.

Authors:  W C Colley; T C Sung; R Roll; J Jenco; S M Hammond; Y Altshuller; D Bar-Sagi; A J Morris; M A Frohman
Journal:  Curr Biol       Date:  1997-03-01       Impact factor: 10.834

7.  Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins.

Authors:  J M Jenco; A Rawlingson; B Daniels; A J Morris
Journal:  Biochemistry       Date:  1998-04-07       Impact factor: 3.162

8.  Characterization of a rat brain phospholipase D isozyme.

Authors:  D S Min; S K Park; J H Exton
Journal:  J Biol Chem       Date:  1998-03-20       Impact factor: 5.157

9.  Cloning, expression, and characterization of a novel phospholipase D complementary DNA from rat brain.

Authors:  T Kodaki; S Yamashita
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.157

10.  Mammalian phospholipase D: activation by ammonium sulfate and nucleotides.

Authors:  S Nakamura; K Shimooku; T Akisue; H Jinnai; T Hitomi; Y Kiyohara; C Ogino; K Yoshida; Y Nishizuka
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

View more
  8 in total

1.  Phospholipase D is Dispensable for Epidermal Growth Factor-Induced Chemotaxis.

Authors:  Chihoko Hirai; Shaymaa Mohamed Mohamed Badawy; Lifang Zhang; Taro Okada; Taketoshi Kajimoto; Shunichi Nakamura
Journal:  Kobe J Med Sci       Date:  2017-05-09

2.  Phospholipase D2 is localized to the rims of the Golgi apparatus in mammalian cells.

Authors:  Zachary Freyberg; Sylvain Bourgoin; Dennis Shields
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

3.  Delta-catenin/NPRAP (neural plakophilin-related armadillo repeat protein) interacts with and activates sphingosine kinase 1.

Authors:  Toshitada Fujita; Taro Okada; Shun Hayashi; Saleem Jahangeer; Noriko Miwa; Shun-ichi Nakamura
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

Review 4.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

Review 5.  Biosynthesis and degradation of mammalian glycosphingolipids.

Authors:  Konrad Sandhoff; Thomas Kolter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

Review 6.  Structure and regulation of human phospholipase D.

Authors:  Forrest Z Bowling; Michael A Frohman; Michael V Airola
Journal:  Adv Biol Regul       Date:  2021-01-03

7.  CtBP1/BARS is an activator of phospholipase D1 necessary for agonist-induced macropinocytosis.

Authors:  Yuki Haga; Noriko Miwa; Saleem Jahangeer; Taro Okada; Shun-ichi Nakamura
Journal:  EMBO J       Date:  2009-03-26       Impact factor: 11.598

8.  Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: high yield and preserved bioactivity.

Authors:  M J E Havenga; L Holterman; I Melis; S Smits; J Kaspers; E Heemskerk; R van der Vlugt; M Koldijk; G J Schouten; G Hateboer; K Brouwer; R Vogels; J Goudsmit
Journal:  Biotechnol Bioeng       Date:  2008-06-01       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.